European Society of Intensive Care Medicine's Avatar

European Society of Intensive Care Medicine

@esicm.bsky.social

523 Followers  |  38 Following  |  421 Posts  |  Joined: 24.01.2025
Posts Following

Posts by European Society of Intensive Care Medicine (@esicm.bsky.social)

Preview
39th Annual Congress - Lisbon - ESICM Make sure to mark your 2026 calendars and prepare for an unforgettable experience!

๐Ÿ“ข #LIVES2026 Call for Abstracts is NOW OPEN! Showcase your research at the 39th Annual Congress of #ESICM. From sepsis to AI, physiology to education โ€” help shape the future of #IntensiveCare

โœจNew: Education & Environmental Sustainability
โ—Deadline: ๐Ÿญ๐Ÿฑ ๐—”๐—ฝ๐—ฟ๐—ถ๐—น ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ, ๐Ÿฎ๐Ÿฏ:๐Ÿฑ๐Ÿต ๐—–๐—˜๐—ง

๐Ÿ‘‰ shorturl.at/vgUJ7

02.03.2026 09:00 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

๐Ÿ“ข Your weekly selection of #articles from the @intenscaremed.bsky.social is here! ๐Ÿ“– ๐—™๐—ผ๐—น๐—น๐—ผ๐˜„ ๐˜‚๐˜€ & stay updated with the latest research, delivered straight to you.

๐Ÿ“ Read all the latest articles here ๐Ÿ‘‰ www.esicm.org/icm-esicm-la...

#ICM #ESICM #Research #MedicalJournals #IntensiveCare

27.02.2026 13:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

๐ŸŽฅ Sepsis is complex, and our understanding is evolving.

Join todayโ€™s #ESICMWebinar on biologically defined endotypes and data-driven subphenotypes. Discover how these advances improve risk stratification and personalise #ICUCare.

๐Ÿ—“๏ธ ๐—ง๐—ผ๐—ฑ๐—ฎ๐˜†, ๐Ÿญ๐Ÿฒ:๐Ÿฌ๐Ÿฌ ๐—–๐—˜๐—ง๐Ÿ‘‰ shorturl.at/qOBbM

#ESICM #IntensiveCare #Sepsis

26.02.2026 09:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Grants - ESICM The ESICM Research Grants provide funding for innovative research projects in intensive care medicine across various disciplines.

๐Ÿ”ฌ The clock is ticking! #ESICMResearch Grants deadline: ๐Ÿฎ๐Ÿต ๐— ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ, ๐Ÿฎ๐Ÿฏ:๐Ÿฑ๐Ÿต ๐—–๐—˜๐—ง.

๐Ÿ’ถ ๐Ÿฎ๐Ÿฐ๐Ÿฌ,๐Ÿฌ๐Ÿฌ๐Ÿฌโ‚ฌ
๐Ÿ”ฌ ๐Ÿด ๐—ด๐—ฟ๐—ฎ๐—ป๐˜๐˜€
๐Ÿค ๐Ÿฏ ๐—ถ๐—ป๐—ฑ๐˜‚๐˜€๐˜๐—ฟ๐˜†-๐˜€๐˜‚๐—ฝ๐—ฝ๐—ผ๐—ฟ๐˜๐—ฒ๐—ฑ ๐—ผ๐—ฝ๐—ฝ๐—ผ๐—ฟ๐˜๐˜‚๐—ป๐—ถ๐˜๐—ถ๐—ฒ๐˜€

Open to #ESICM members <40 or within 5 years of a permanent post. Multicentre & multinational projects required.

โŒ› Apply now!๐Ÿ‘‰ www.esicm.org/research/awa...

25.02.2026 13:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
LIVES Physiology โ€“ Prague - ESICM Join us for engaging lectures and interactive case-based sessions, perfect for intensive care clinicians looking to refresh and deepen their understanding of physiology.

๐ŸŒ #LIVESPhysiology brings physiology back to the heart of ICU decisions.

Join international experts in Prague for interactive, case-based sessions on ๐˜ƒ๐—ฒ๐—ป๐˜๐—ถ๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป, ๐—ต๐—ฎ๐—ฒ๐—บ๐—ผ๐—ฑ๐˜†๐—ป๐—ฎ๐—บ๐—ถ๐—ฐ๐˜€, ๐˜€๐—ต๐—ผ๐—ฐ๐—ธ, ๐—˜๐—–๐— ๐—ข, ๐—บ๐—ถ๐—ฐ๐—ฟ๐—ผ๐—ฐ๐—ถ๐—ฟ๐—ฐ๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป & ๐—ป๐—ฒ๐˜‚๐—ฟ๐—ผ๐—ฝ๐—ต๐˜†๐˜€๐—ถ๐—ผ๐—น๐—ผ๐—ด๐˜†.

๐Ÿ”— www.esicm.org/events/lives...

#ESICM #IntensiveCare #ICU

25.02.2026 10:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Clinical Ethics and End-of-Life Care e-Course March 24-25, 2026 | Online

๐ŸŽ“ Join the #ESICM ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—˜๐˜๐—ต๐—ถ๐—ฐ๐˜€ & ๐—˜๐—ป๐—ฑ-๐—ผ๐—ณ-๐—Ÿ๐—ถ๐—ณ๐—ฒ ๐—–๐—ฎ๐—ฟ๐—ฒ course! Learn key skills in ethics, communication, prognostication, shared decision-making and palliative care to improve end-of-life practice in the ICU.

๐Ÿ—“๏ธ ๐Ÿฎ๐Ÿฐโ€“๐Ÿฎ๐Ÿฑ ๐— ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ

๐Ÿ”— Register now & advance your practice!๐Ÿ‘‰ www.esicm.org/end-of-life-...

24.02.2026 16:00 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Survey: ICU resilience, stress and support โ€“ Exploring healthcare security Take this survey powered by surveymonkey.com. Create your own surveys for free.

๐Ÿ”ฌ๐—Ÿ๐—ฎ๐˜€๐˜ ๐Ÿฐ ๐—ฑ๐—ฎ๐˜†๐˜€ ๐˜๐—ผ ๐—ฝ๐—ฎ๐—ฟ๐˜๐—ถ๐—ฐ๐—ถ๐—ฝ๐—ฎ๐˜๐—ฒ! How resilient is your #ICU team under pressure?
Take #ESICMโ€™s 5-min survey on #ICUResilience, stress & preparedness. Help us understand how teams cope with high-stress situations!

๐Ÿ—“๏ธDeadline ๐Ÿฎ๐Ÿด ๐—™๐—ฒ๐—ฏ, ๐Ÿฎ๐Ÿฏ:๐Ÿฑ๐Ÿฑ ๐—–๐—˜๐—ง
๐Ÿ‘‰ www.surveymonkey.com/r/L2RJ5CD

#ESICMSurvey #IntensiveCare

24.02.2026 09:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Video thumbnail

๐ŸŒ ๐ŸŒŠ Where science meets the sea. #EuroMed 2026 comes to ๐—”๐—ท๐—ฎ๐—ฐ๐—ฐ๐—ถ๐—ผ (๐Ÿฎ๐Ÿฌโ€“๐Ÿฎ๐Ÿฎ ๐— ๐—ฎ๐˜†) on the stunning island of Corsica.

โณ Abstract deadline: ๐Ÿฎ ๐— ๐—ฎ๐—ฟ๐—ฐ๐—ต, ๐—ป๐—ผ๐—ผ๐—ป ๐—–๐—˜๐—ง. Share your work, join the debate & shape the future of #IntensiveCare.

Join us in Ajaccio. ๐—ฅ๐—ฒ๐—ด๐—ถ๐˜€๐˜๐—ฒ๐—ฟ ๐˜๐—ผ๐—ฑ๐—ฎ๐˜†! ๐Ÿ‘‰ www.esicm.org/events/euro-...

#ESICM

23.02.2026 09:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

๐Ÿ“ข Your weekly selection of #articles from the @intenscaremed.bsky.social is here! ๐Ÿ“– ๐—™๐—ผ๐—น๐—น๐—ผ๐˜„ ๐˜‚๐˜€ & stay updated with the latest research, delivered straight to you.

๐Ÿ“ Read all the latest articles here ๐Ÿ‘‰ www.esicm.org/icm-online-l...

#ICM #ESICM #Research #MedicalJournals #IntensiveCare

20.02.2026 13:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

๐ŸŽฅ Sepsis is complex and heterogeneous. Understanding its variability is key to advancing #precisionmedicine.

Join this #ESICMWebinar on ๐—ฏ๐—ถ๐—ผ๐—น๐—ผ๐—ด๐—ถ๐—ฐ๐—ฎ๐—น๐—น๐˜† ๐—ฑ๐—ฒ๐—ณ๐—ถ๐—ป๐—ฒ๐—ฑ ๐—ฒ๐—ป๐—ฑ๐—ผ๐˜๐˜†๐—ฝ๐—ฒ๐˜€ ๐—ฎ๐—ป๐—ฑ ๐—ฑ๐—ฎ๐˜๐—ฎ-๐—ฑ๐—ฟ๐—ถ๐˜ƒ๐—ฒ๐—ป ๐˜€๐˜‚๐—ฏ๐—ฝ๐—ต๐—ฒ๐—ป๐—ผ๐˜๐˜†๐—ฝ๐—ฒ๐˜€ โ€” and what they mean for personalised care.

๐Ÿ—“๏ธ ๐Ÿฎ๐Ÿฒ ๐—™๐—ฒ๐—ฏ, ๐Ÿญ๐Ÿฒ:๐Ÿฌ๐Ÿฌ ๐—–๐—˜๐—ง ๐Ÿ‘‰ shorturl.at/qOBbM

#IntensiveCare

20.02.2026 09:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Video thumbnail

๐ŸŒ Join us in Japan for #EuroJapanForum 2026!

On ๐Ÿฑโ€“๐Ÿฒ ๐— ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ, meet us in Yokohama for the second ๐—˜๐˜‚๐—ฟ๐—ผ-๐—๐—ฎ๐—ฝ๐—ฎ๐—ป ๐—™๐—ผ๐—ฟ๐˜‚๐—บ, alongside the 53rd JSICM Annual Meeting.

Learn from top international experts & explore key ICU challenges ๐Ÿ‘‰ www.esicm.org/events/euro-...

#ESICM #ESICMJSICM #IntensiveCare

19.02.2026 13:02 โ€” ๐Ÿ‘ 2    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

๐Ÿ“นJoin us today for the ๐—ธ๐—ถ๐—ฐ๐—ธ-๐—ผ๐—ณ๐—ณ ๐˜„๐—ฒ๐—ฏ๐—ถ๐—ป๐—ฎ๐—ฟ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ฆ๐—ฒ๐—ฝ๐˜€๐—ถ๐˜€, ๐—ฆ๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐—ฒ ๐—œ๐—ป๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป๐˜€ & ๐—ฆ๐˜๐—ฒ๐˜„๐—ฎ๐—ฟ๐—ฑ๐˜€๐—ต๐—ถ๐—ฝ ๐—Ÿ๐—ฒ๐—ฎ๐—ฟ๐—ป๐—ถ๐—ป๐—ด ๐—ฃ๐—ฎ๐˜๐—ต๐˜„๐—ฎ๐˜†. Discover a programme combining self-paced learning, interactive expert sessions and hands-on training & meet the faculty!

๐Ÿค Supported by bioMรฉrieux

๐Ÿ”—๐—ง๐—ผ๐—ฑ๐—ฎ๐˜†, ๐Ÿญ๐Ÿฒ:๐Ÿฌ๐Ÿฌ ๐—–๐—˜๐—ง๐Ÿ‘‰ shorturl.at/jHLlb

#ESICM

19.02.2026 09:30 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Video thumbnail

๐ŸŒŽ Join the 2nd edition of #EuroBrazil in collaboration with AMIB! This landmark meeting brings together leading experts in #IntensiveCare from Europe, Brazil & worldwide to share science, innovation and real-world ICU practice!

๐Ÿ“Sรฃo Paulo
๐Ÿ“… 9โ€“11 April

๐Ÿ‘‰ www.esicm.org/events/euro-...

#ESICM

18.02.2026 13:01 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Foundation Course in Acute Respiratory Failure and Mechanical Ventilation: April 3 - 4 April 8-9, 2026 | Online

๐ŸŽ“ Master the fundamentals of ๐—”๐—ฐ๐˜‚๐˜๐—ฒ ๐—ฅ๐—ฒ๐˜€๐—ฝ๐—ถ๐—ฟ๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—™๐—ฎ๐—ถ๐—น๐˜‚๐—ฟ๐—ฒ & ๐— ๐—ฒ๐—ฐ๐—ต๐—ฎ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ฉ๐—ฒ๐—ป๐˜๐—ถ๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป! Join the Foundation Course to strengthen your ICU knowledge in gas exchange, ventilation modes, lung mechanics, weaning, NIV & HFNC

๐Ÿ—“๏ธ ๐Ÿดโ€“๐Ÿต ๐—”๐—ฝ๐—ฟ๐—ถ๐—น | ๐—ข๐—ป๐—น๐—ถ๐—ป๐—ฒ

๐Ÿ† 5 funded fellowships available
๐Ÿ”— www.esicm.org/acute-respir...

17.02.2026 16:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Video thumbnail

๐ŸŒ3 days. Pure #physiology. At the bedside. Join international experts at #LIVESPhysiology in ๐—ฃ๐—ฟ๐—ฎ๐—ด๐˜‚๐—ฒ (๐Ÿฐโ€“๐Ÿฒ ๐—๐˜‚๐—ป๐—ฒ) for case-based sessions on ๐—ฟ๐—ฒ๐˜€๐—ฝ๐—ถ๐—ฟ๐—ฎ๐˜๐—ผ๐—ฟ๐˜†, ๐—ต๐—ฎ๐—ฒ๐—บ๐—ผ๐—ฑ๐˜†๐—ป๐—ฎ๐—บ๐—ถ๐—ฐ, ๐—บ๐—ถ๐—ฐ๐—ฟ๐—ผ๐—ฐ๐—ถ๐—ฟ๐—ฐ๐˜‚๐—น๐—ฎ๐˜๐—ผ๐—ฟ๐˜†, ๐—ฎ๐—ฏ๐—ฑ๐—ผ๐—บ๐—ถ๐—ป๐—ฎ๐—น & ๐—ป๐—ฒ๐˜‚๐—ฟ๐—ผ๐—ฝ๐—ต๐˜†๐˜€๐—ถ๐—ผ๐—น๐—ผ๐—ด๐˜†, turning core principles into real #ICU decisions

๐Ÿ”— www.esicm.org/events/lives...
#ESICM

16.02.2026 15:01 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Systemic Inflammation and Sepsis - ESICM The Systemic Inflammation and Sepsis section offers education and research on sepsis, antimicrobial stewardship, and severe infections in critical care.

๐Ÿ“ฃ Presenting the 7th #PointOfView, where ESICM specialists provide a ๐˜€๐˜‚๐—บ๐—บ๐—ฎ๐—ฟ๐˜† ๐—ผ๐—ป ๐—ฎ ๐˜€๐—ฒ๐—น๐—ฒ๐—ฐ๐˜๐—ฒ๐—ฑ ๐˜๐—ผ๐—ฝ๐—ถ๐—ฐ, ๐—ณ๐—ฟ๐—ผ๐—บ ๐˜๐—ต๐—ฒ๐—ถ๐—ฟ ๐˜‚๐—ป๐—ถ๐—พ๐˜‚๐—ฒ ๐—ฝ๐—ฒ๐—ฟ๐˜€๐—ฝ๐—ฒ๐—ฐ๐˜๐—ถ๐˜ƒ๐—ฒ!

Prepared by #ESICM #SISSection โฉ๐—”๐—ก๐——๐—ฅ๐—ข๐— ๐—˜๐——๐—”-๐—ฆ๐—›๐—ข๐—–๐—ž-๐Ÿฎ: ๐—ฃ๐—ฒ๐—ฟ๐˜€๐—ผ๐—ป๐—ฎ๐—น๐—ถ๐˜€๐—ฒ๐—ฑ ๐—›๐—ฒ๐—บ๐—ผ๐—ฑ๐˜†๐—ป๐—ฎ๐—บ๐—ถ๐—ฐ ๐—ฅ๐—ฒ๐˜€๐˜‚๐˜€๐—ฐ๐—ถ๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ง๐—ฎ๐—ฟ๐—ด๐—ฒ๐˜๐—ถ๐—ป๐—ด ๐—–๐—ฎ๐—ฝ๐—ถ๐—น๐—น๐—ฎ๐—ฟ๐˜† ๐—ฅ๐—ฒ๐—ณ๐—ถ๐—น๐—น ๐—ง๐—ถ๐—บ๐—ฒ ๐—ถ๐—ป ๐—˜๐—ฎ๐—ฟ๐—น๐˜† ๐—ฆ๐—ฒ๐—ฝ๐˜๐—ถ๐—ฐ ๐—ฆ๐—ต๐—ผ๐—ฐ๐—ธ

Read the paper here! ๐Ÿ‘‡

16.02.2026 09:00 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

๐Ÿ“ข Your weekly selection of #articles from the @intenscaremed.bsky.social is here! ๐Ÿ“– ๐—™๐—ผ๐—น๐—น๐—ผ๐˜„ ๐˜‚๐˜€ & stay updated with the latest research, delivered straight to you.

๐Ÿ“ Read all the latest articles here ๐Ÿ‘‰ www.esicm.org/icm-esicm-la...

#ICM #ESICM #Research #MedicalJournals #IntensiveCare

13.02.2026 13:13 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

๐Ÿ“นJoin us next week for the ๐—ธ๐—ถ๐—ฐ๐—ธ-๐—ผ๐—ณ๐—ณ ๐˜„๐—ฒ๐—ฏ๐—ถ๐—ป๐—ฎ๐—ฟ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—ฆ๐—ฒ๐—ฝ๐˜€๐—ถ๐˜€, ๐—ฆ๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐—ฒ ๐—œ๐—ป๐—ณ๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป๐˜€ & ๐—ฆ๐˜๐—ฒ๐˜„๐—ฎ๐—ฟ๐—ฑ๐˜€๐—ต๐—ถ๐—ฝ ๐—Ÿ๐—ฒ๐—ฎ๐—ฟ๐—ป๐—ถ๐—ป๐—ด ๐—ฃ๐—ฎ๐˜๐—ต๐˜„๐—ฎ๐˜†โ€”combining self-learning, interactive teaching & hands-on practice. Meet the faculty & explore the journey.

๐ŸคSupported by bioMรฉrieux

๐Ÿญ๐Ÿต ๐—™๐—ฒ๐—ฏ, ๐Ÿญ๐Ÿฒ:๐Ÿฌ๐Ÿฌ ๐—–๐—˜๐—ง ๐Ÿ‘‰ lives-stream.esicm.org/en/catalog/w...

13.02.2026 09:31 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Translational Biology Research In Development and Global Engagement in Intensive Care (T-BRIDGE) Survey Take this survey powered by surveymonkey.com. Create your own surveys for free.

๐Ÿ”ฌ Take part in the ๐—ง-๐—•๐—ฅ๐—œ๐——๐—š๐—˜ ๐—ฆ๐˜‚๐—ฟ๐˜ƒ๐—ฒ๐˜†, an initiative of the #ESICM #TransBioSection, ๐—ฒ๐˜…๐—ฝ๐—น๐—ผ๐—ฟ๐—ถ๐—ป๐—ด ๐—ฎ๐˜„๐—ฎ๐—ฟ๐—ฒ๐—ป๐—ฒ๐˜€๐˜€, ๐˜‚๐—ป๐—ฑ๐—ฒ๐—ฟ๐˜€๐˜๐—ฎ๐—ป๐—ฑ๐—ถ๐—ป๐—ด & ๐˜๐—ต๐—ฒ ๐—ฝ๐—ฒ๐—ฟ๐—ฐ๐—ฒ๐—ถ๐˜ƒ๐—ฒ๐—ฑ ๐—ฟ๐—ฒ๐—น๐—ฒ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ผ๐—ณ ๐˜๐—ฟ๐—ฎ๐—ป๐˜€๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—บ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ถ๐—ป๐—ฒ ๐˜„๐—ถ๐˜๐—ต๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—˜๐—ฆ๐—œ๐—–๐—  ๐—ฐ๐—ผ๐—บ๐—บ๐˜‚๐—ป๐—ถ๐˜๐˜†.

Have your say, complete the survey today!๐Ÿ‘‰ www.surveymonkey.com/r/T-BRIDGE
#ESICMSurvey #IntensiveCare

12.02.2026 13:02 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

๐ŸŽฅJoin todayโ€™s #ESICMWebinar & dive inside the airways to learn how to perform bronchoscopy safely and effectively in critically ill patients.

๐Ÿ“ฃTackle hypoxemia, haemodynamic instability & moreโ€”while maximising safety and yield in the ICU.

๐Ÿ—“๏ธ๐—ง๐—ผ๐—ฑ๐—ฎ๐˜†, ๐Ÿญ๐Ÿฒ:๐Ÿฌ๐Ÿฌ ๐—–๐—˜๐—ง๐Ÿ‘‰ shorturl.at/OFbfO

#ESICM #IntensiveCare

12.02.2026 09:30 โ€” ๐Ÿ‘ 2    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

๐ŸŒ Join the #EuroJapanForum 2026!

ESICM & JSICM meet in ๐—ฌ๐—ผ๐—ธ๐—ผ๐—ต๐—ฎ๐—บ๐—ฎ, ๐Ÿฑโ€“๐Ÿฒ ๐— ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ, alongside the 53rd JSICM Annual Meeting.

Learn from top ESICM faculty and explore shock, organ failure & new Sepsis Guidelines.

๐Ÿ‘‰ www.esicm.org/events/euro-...

#ESICM #EuroJapan2026 #ESICMJSICM #IntensiveCare

11.02.2026 13:02 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

โœจToday is ๐—œ๐—ป๐˜๐—ฒ๐—ฟ๐—ป๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐——๐—ฎ๐˜† ๐—ผ๐—ณ ๐—ช๐—ผ๐—บ๐—ฒ๐—ป & ๐—š๐—ถ๐—ฟ๐—น๐˜€ ๐—ถ๐—ป ๐—ฆ๐—ฐ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒโœจ

Celebrating women shaping #Science & #IntensiveCare. By combining ๐—”๐—œ, ๐—ฆ๐—ง๐—˜๐— , ๐˜€๐—ผ๐—ฐ๐—ถ๐—ฎ๐—น ๐˜€๐—ฐ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐—ณ๐—ถ๐—ป๐—ฎ๐—ป๐—ฐ๐—ฒ, we can build ๐—ถ๐—ป๐—ฐ๐—น๐˜‚๐˜€๐—ถ๐˜ƒ๐—ฒ ๐—ถ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป where women lead, innovate & thrive!

Read more here! ๐Ÿ‘‰ www.esicm.org/internationa...

#IDWGS2026 #ESICM

11.02.2026 09:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
EDIC II Preparation Course - ESICM On site at LIVES 2023 Milan

๐ŸŽ“ Preparing for the EDIC II exam? Get exam-ready with confidence. Register for the EDIC II Preparation Course to familiarise yourself with the exam format, mock cases and expert tipsโ€”led by experienced EDIC examiners.

๐Ÿ—“๏ธ ๐Ÿญ๐Ÿฎ ๐— ๐—ฎ๐—ฟ๐—ฐ๐—ต ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฒ
๐Ÿ‘‰ www.esicm.org/courses-2/ed...

#ESICM #EDICII #IntensiveCare

10.02.2026 16:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Survey: ICU resilience, stress and support โ€“ Exploring healthcare security Take this survey powered by surveymonkey.com. Create your own surveys for free.

๐Ÿ”ฌ How resilient is your #ICU team under pressure?
Take #ESICMโ€™s 5-minute survey on #ICUResilience, stress & preparedness and help us understand how teams cope with high-stress situations!

๐Ÿ—“๏ธ ๐——๐—ฒ๐—ฎ๐—ฑ๐—น๐—ถ๐—ป๐—ฒ: ๐Ÿฎ๐Ÿด ๐—™๐—ฒ๐—ฏ, ๐Ÿฎ๐Ÿฏ:๐Ÿฑ๐Ÿฑ ๐—–๐—˜๐—ง
๐Ÿ‘‰ www.surveymonkey.com/r/L2RJ5CD

#ESICMSurvey #IntensiveCare #ICUInnovation

09.02.2026 15:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

๐Ÿ—ณ๏ธ 2026 #ESICMElections are coming! Apply as a candidate or vote for the future leaders shaping #ICUCare.

โœ… Only paid 2026 #ESICMMembership ๐—ฏ๐—ฒ๐—ณ๐—ผ๐—ฟ๐—ฒ ๐—ฏ๐—ฎ๐—น๐—น๐—ผ๐˜๐˜€ ๐—ผ๐—ฝ๐—ฒ๐—ป are eligible to vote!

Check all available positions and save the date! ๐Ÿ‘‰ www.esicm.org/the-esicm/el...

#ESICM #IntensiveCare

09.02.2026 09:00 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

๐Ÿ“ข Your ๐—น๐—ฎ๐˜๐—ฒ๐˜€๐˜ ๐—ถ๐˜€๐˜€๐˜‚๐—ฒ of the @intenscaremed.bsky.social with the latest articles is here! ๐Ÿ“– ๐—™๐—ผ๐—น๐—น๐—ผ๐˜„ ๐˜‚๐˜€ & stay updated with the latest research, delivered straight to you.

๐Ÿ“ Read all the latest articles here ๐Ÿ‘‰ www.esicm.org/icm-latest-i...

#ICM #ESICM #Research #MedicalJournals #IntensiveCare

06.02.2026 13:01 โ€” ๐Ÿ‘ 3    ๐Ÿ” 1    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Post image Post image Post image Post image

๐ŸŒ ๐—œ๐—ป๐˜๐—ฒ๐—ป๐˜€๐—ถ๐˜ƒ๐—ฒ ๐—–๐—ฎ๐—ฟ๐—ฒ ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ถ๐˜€ ๐˜‚๐—ป๐—ฑ๐—ฒ๐—ฟ๐˜„๐—ฎ๐˜†! ๐Ÿš€ Clinicians, innovators & data experts unite in Amsterdam to challenge practice and shape the future of intensive care.

๐Ÿ’กInspiring ideas, real clinical impact ahead.

๐Ÿ‘ Thanks to GE Healthcare, Philips & VirtauliSurg.

#ESICM #ESICMInnovation #ICUInnovation

05.02.2026 18:30 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

๐ŸŽฅ Bronchoscopy is essential in the ICUโ€”but comes with risks in critically ill patients.

๐Ÿ“ฃ Join our #ESICMWebinar to explore safe, effective bronchoscopy, from managing hypoxemia to improving diagnostic yield and patient outcomes!

๐Ÿ—“๏ธ ๐Ÿญ๐Ÿฎ ๐—™๐—ฒ๐—ฏ๐—ฟ๐˜‚๐—ฎ๐˜†๐—ฟ, ๐Ÿญ๐Ÿฒ:๐Ÿฌ๐Ÿฌ ๐—–๐—˜๐—ง ๐Ÿ‘‰ shorturl.at/1x9Hq

#ESICM #IntensiveCare

05.02.2026 08:30 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Video thumbnail

๐ŸŒBe part of inspiring discussions, hands-on sessions & global expertise shaping tomorrowโ€™s intensive care. Donโ€™t miss the ๐—œ๐—ป๐˜๐—ฒ๐—ป๐˜€๐—ถ๐˜ƒ๐—ฒ ๐—–๐—ฎ๐—ฟ๐—ฒ ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป starting tomorrow!

โœจSupported by GE Healthcare, Philips & VirtualiSurg

๐Ÿ”— www.esicm.org/events/inten...

#ESICM #ESICMInnovation

04.02.2026 14:02 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
Attitudes of medical doctors and pharmacists towards the pharmacological management of anemia in critically ill patients We are contacting you to request your participation in a study aimed at gaining insights into anemia management in survivors of critical illness. 1. Research Title and Ethics Committee Approval The title of this survey is "Attitudes of medical doctors and pharmacists towards the pharmacological management of anemia in critically ill patients". This research has been reviewed by the Epidemiological Research Ethics Committee of Hiroshima University and approved by the Director of Hiroshima University. 2. Research Collaborating Institutions and Principal Investigator This survey is being conducted with the collaboration of Dr. Yuki Kataoka (Nagoya University), Dr. Richard Bourne (University of Manchester), Dr. Cathrine McKenzie (University of Southampton), Dr. Kent Doi (The University of Tokyo Hospital), Dr. Simon Oczkowski and Dr. Joanna Dionne (McMaster University), and Dr. Alexander Vlaar (Amsterdam University Medical Centers). 3. Research Purpose and Significance The purpose of this study is to explore the knowledge, attitudes, and clinical practices of medical doctors and pharmacists regarding the pharmacological management of anemia in critically ill patients. Anemia is a frequent condition in Intensive Care Unit (ICU) patients, often persisting after discharge and leading to various complications such as readmission and mortality. Although โ€œErythropoiesis-stimulating agents (ESA) and Hypoxia-inducible factor prolyl-4-hydroxylase inhibitors (HIF-PHI)โ€ has been proposed, their clinical adoption remains limited due to uncertainty including unclear patient selection criteria. Therefore, by identifying current clinical perspectives and practices, this survey aims to clearly barriers to implementation and contribute to the development of more effective and evidence-informed anemia management strategies in the ICU setting. 4. Research Method and Period This study is a scenario-based questionnaire survey. The research period is from the date of ethics approval to December 31, 2026. The response period for the questionnaire is set at six months from the initial survey recruitment email. This survey takes approximately 20 minutes to complete. The information obtained will be used only for research purposes and be shared and analyzed with Nagoya University. 5. Reason for Selection as Research Subjects This study targets medical doctors or pharmacists who have experience managing or have managed critically ill patients (excluding post-operative patients) admitted to the ICU. The medical doctors and pharmacist members of these societies match the criteria of the research. 6. Burdens, Anticipated Risks, and Benefits for Research Subjects Burden: Approximately 15 minutes required to complete the questionnaire. Risk: Possibility of personal information leakage if email addresses contain personal information. As a countermeasure, email addresses will be immediately deleted during data compilation. Benefit: While there are no direct benefits, participants can contribute to improving pharmacological treatments of anemia in critically ill patients. 7. Consent and Withdrawal By responding to the questionnaire, you are considered to have consented to participate in this study. Consent can be withdrawn even after responding, as long as it's before data compilation. There are no disadvantages for not consenting or withdrawing consent. 8. Method of Disclosing Research Information The results of this study will be made public through paper submissions and conference presentations. 9. Method of Obtaining/Viewing Research Protocol The research protocol and materials related to research methods can be obtained or viewed to the extent that it does not compromise personal information protection and research originality. If you wish to do so, please contact us using the contact information below. 10. Handling of Personal Information Collected information will be processed and analyzed in a form that cannot identify individuals. 11. Storage and Disposal of Information Collected information will be stored for 5 years after the end of the research and then appropriately disposed of. 12. Research Funding Source and Conflicts of Interest This research is conducted with the university's operational grants, and the researchers have no conflicts of interest. 13. Handling of Research Results Research results will be anonymized and statistically analyzed. Individual results will not be disclosed. 14. Response to Inquiries Questions and inquiries about the research will be addressed at the following contact. Details of the research plan are published at the following link: https://osf.io/6b94z/ Sincerely, Shodai Yoshihiro, Mitsuaki Nishikimi, Nobuaki Shime, Hiroaki Matsuo Hiroshima University Hospital shodaidotet@gmail.com

๐Ÿ”ฌ New #ESICMSurvey! Share your views on ๐—ฎ๐—ป๐—ฎ๐—ฒ๐—บ๐—ถ๐—ฎ ๐—บ๐—ฎ๐—ป๐—ฎ๐—ด๐—ฒ๐—บ๐—ฒ๐—ป๐˜ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—œ๐—–๐—จ. Doctors & pharmacists, help us explore knowledge, attitudes & practices to improve care.

โœ”๏ธ Approved by ESICM Pharma & APM Sections & Transfusion Task Force

๐Ÿ”— Take the survey ๐Ÿ‘‰ shorturl.at/GCFrh

#ESICM #ICU #Survey #Anaemia

03.02.2026 16:01 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0